DiscGenics Study Data Update

DiscGenics IDCT Injection

DiscGenics announced positive two-year clinical data from its first-in-human clinical study of Injectable Discogenic Cell Therapy (IDCT), an allogeneic discogenic progenitor cell therapy for lumbar degenerative disc disease (DDD).

In the prospective, randomized, double-blind, vehicle- and placebo-controlled, multicenter clinical study, high...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us